Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/13/2008

on to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

JAZZ PHARMACEUTICALS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Revenues:

Product sales, net $14,860 $11,890 $53,536 $43,299

Royalties, net 332 258 1,156 594

Contract revenue 285 301 10,611 963

Total revenues 15,477 12,449 65,303 44,856

Operating expenses:

Cost of product sales

(excluding amortization of

acquired developed

technology) 3,283 1,601 8,903 6,968

Research and development 20,540 13,036 69,792 54,956

Selling, general and

administrative 27,958 12,543 78,540 51,384

Intangible asset

amortization 2,280 2,400 9,217 9,600

Intangible asset impairment 20,160 - 20,160 -

Provision for government

settlement - - 17,469 -

Total operating expenses 74,221 29,580 204,081 122,908

Loss from operations (58,744) (17,131) (138,778) (78,052)

Interest income 1,582 619 5,942 2,307

Interest expense (3,554) (3,311) (13,647) (14,129)

Other income (expense)
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
2. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
3. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
4. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
5. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
6. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
7. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
8. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
9. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
11. Jazz Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... - Oncothyreon Inc. (NASDAQ: ONTY ) today ... underwritten offerings of 10,000,000 shares of its Common Stock ... share, for expected gross proceeds of $20 million and ... at a price to the public of $2,000.00 per ... share of Series A Convertible Preferred Stock is non-voting ...
(Date:9/18/2014)... 18, 2014 SeqLL Inc., the ... technology, announced today the closing of a $1M ... by Genomic Diagnostic Technologies, will increase the power ... , Founded in March 2013 by Daniel Jones, ... at Helicos BioSciences, SeqLL has continued to offer ...
(Date:9/18/2014)... Scientists at USC have developed a new microscopy ... in living animals at higher-than-ever resolution. , Dubbed ... allows imaging resolutions that are an order of ... insights into the behavior of biomolecules at the ... Sept. 18 by Nature Communications , the ...
(Date:9/18/2014)... Diego, CA (PRWEB) September 18, 2014 ... promotions which include Sartorius/Biohit, Socorex, Capp, and AccuPet ... with volumes of 100 uL or less and ... oncology, and forensic applications. , The micropipette ... high quality and economic alternative products to help ...
Breaking Biology Technology:Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3SeqLL Closes Series-A Funding Round for Expansion of Single Molecule Sequencing 2Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes 2Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes 3
... Gen-Probe Incorporated,(Nasdaq: GPRO ) announced today that ... Global Healthcare Conference in Miami Beach on March,18, 2008 ... Cowen and,Company 28th Annual Healthcare Conference in Boston on ... presentations are scheduled to,be webcast live and may be ...
... - Sales up 16% - Profit Before R&D up 19% - Net Profit (Group Share) up 12% - ... approved the 2007 consolidated financial statements:, (EUR millions) 2007 ... ... sales % change, Sales ...
... MEMBER HAS CLINCIAL, CORPORATE AND REGULATORY EXPERIENCE IN STEM ... ... ,ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative,products ... Rao, Vice President, Stem Cells and Regenerative Medicine at,Invitrogen Corporation, has ...
Cached Biology Technology:Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences 2STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure 2STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure 3ThermoGenesis Names Dr. Mahendra Rao to Board of Directors 2ThermoGenesis Names Dr. Mahendra Rao to Board of Directors 3ThermoGenesis Names Dr. Mahendra Rao to Board of Directors 4
(Date:9/18/2014)... carbon and nitrogen comprise all spheres of our ... have caused imbalances and perturbations that resulted in ... GHGs result in climate changes which influence the ... the atmosphere. Understanding these feedback mechanisms has become ... science during the past three decades. , In ...
(Date:9/18/2014)... to 400 kilometres in search of a home, which makes ... spend their entire adult lives under the protection of their ... ocean, says study co-author, Dr Hugo Harrison from the ARC ... James Cook University. , "In the past we haven,t known ... glimpse into how far they can swim, crossing large tracts ...
(Date:9/17/2014)... his doctoral student have designed a device based on ... fog and dew., The device could provide water in ... globe., Cheng Luo, professor in the Mechanical & Aerospace ... same College of Engineering department, published "Bioinspired Plate-Based Fog ... Chemical Society) Applied Materials & Interfaces ...
Breaking Biology News(10 mins):Greenhouse gas research enters a new era 2Nemo's epic journey to find a new home 2Shorebird's beak inspires UT Arlington research on water collection 2
... belonging to an ancient lemur has revealed a mysterious joint ... professor of anatomy at the University of Alberta in Edmonton, ... the first hand bones ever found of Hadropithecus stenognathus, a ... discovered in 2003 in a cave in southeastern Madagascar, an ...
... rice breeder and one day within a large field you ... been looking for. You happily take your special plant to ... event was due to inactivation of a single gene. This ... grown in different parts of the world, well adapted to ...
... passerine birds is a conspicuous and exaggerated display shaped ... or mate attraction. At the level of the individual, ... Paola Laiolo and colleagues at the Spanish Council ... Duponts lark in north-eastern Spain and found an association ...
Cached Biology News:Ancient lemur's little finger poses mystery 2Less can be more, for plant breeders too 2Less can be more, for plant breeders too 3
...
prototype Nco I...
Based on Silica membrane matrix beads. The kit is designed for the purification of DNA (20 bp - 100 bp) from TAE/TBE agarose gels. Run time is approximately 45 minutes....
Modified and insect cell culture tested....
Biology Products: